Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

NCT00981903 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT00981903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00981903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2005
Completion date
October 31, 2015
Enrollment
131 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, venous thromboembolism